Ayala Pharmaceuticals EBIT margin
Cos'è EBIT margin di Ayala Pharmaceuticals?
EBIT margin di Ayala Pharmaceuticals Inc. è -5,723.60%
Qual è la definizione di EBIT margin?
EBIT margin is a profitability ratio that measures earnings of the company as a percentage of revenue without taking into account the effect of taxes and interest.
ttm (trailing twelve months)
EBIT margin measures the profitability and operational efficiency of a company. It compares the amount of money that remains after the cost of goods and all operating expenses are subtracted from net revenue to sales. EBIT margin is calculated as earnings before interest and taxes divided by net revenue.
EBIT and EBIT margin evaluate how well a business manages its operations. Interest and taxes are not operating expenses and don’t impact operating efficiency. EBIT margin is usually used to compare operational efficiency and profitability of companies within the same industry. Taxes can vary by location thus excluding them from the calculation gives a better basis for comparing different companies.
EBIT and operating income are often used interchangeably, but there is a difference between them, which can cause the numbers to give different results. The key difference is that operating income does not include non-operating income, non-operating expenses, and other income.
EBIT margin di aziende nel Health Care settore su NASDAQ rispetto a Ayala Pharmaceuticals
Cosa fa Ayala Pharmaceuticals?
advaxis (nasdaq: adxs) is a late -stage biotechnology company developing multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer. the advaxis technology, using bioengineered live attenuated bacteria, listeria monocytogenes (lm), actively suppresses key components in the tumor microenvironment that contribute to the tumors growth and protection from immunologic attack.
Aziende con ebit margin simili a Ayala Pharmaceuticals
- Entheon Biomedical ha EBIT margin di -6,027.18%
- Green Hygienics ha EBIT margin di -6,022.25%
- VYNE Therapeutics ha EBIT margin di -5,849.18%
- Desert Metals ha EBIT margin di -5,802.10%
- Rafael Inc ha EBIT margin di -5,782.78%
- Clene Nanomedicine ha EBIT margin di -5,778.73%
- Ayala Pharmaceuticals ha EBIT margin di -5,723.60%
- Touchpoint ha EBIT margin di -5,664.29%
- Lyra Therapeutics ha EBIT margin di -5,567.64%
- Proseed India ha EBIT margin di -5,566.02%
- Energous Corp ha EBIT margin di -5,285.48%
- Orgenesis Inc ha EBIT margin di -5,274.17%
- Zonetail ha EBIT margin di -5,268.44%